Pilot Study to Evaluate the Tolerability of Velcade (Bortezomib) and Pravastatin for the Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Phase of Trial: Phase I
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Bortezomib (Primary) ; Pravastatin
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 07 Feb 2017 Planned End Date changed from 1 Aug 2019 to 1 Aug 2020.
- 07 Feb 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 02 Jul 2015 New trial record